These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 3047215)
1. Comparison of beclomethasone dipropionate and prednisolone 21-phosphate enemas in the treatment of ulcerative proctitis. van der Heide H; van den Brandt-Gradel V; Tytgat GN; Endert E; Wiltink EH; Schipper ME; Dekker W J Clin Gastroenterol; 1988 Apr; 10(2):169-72. PubMed ID: 3047215 [TBL] [Abstract][Full Text] [Related]
2. Comparison of beclomethasone dipropionate (2 and 3 mg) and prednisolone sodium phosphate enemas (30 mg) in the treatment of ulcerative proctitis. An adrenocortical approach. Mulder CJ; Endert E; van der Heide H; Houthoff HJ; Wiersinga W; Wiltink EH; Tytgat GN Neth J Med; 1989 Aug; 35(1-2):18-24. PubMed ID: 2779692 [TBL] [Abstract][Full Text] [Related]
3. Beclomethasone dipropionate enemas versus prednisolone sodium phosphate enemas in the treatment of distal ulcerative colitis. Campieri M; Cottone M; Miglio F; Manenti F; Astegiano M; D'Arienzo A; Manguso F; D'Albasio G; Bonanomi A; Galeazzi R; Orlando A; Castiglione GN; Gionchetti P Aliment Pharmacol Ther; 1998 Apr; 12(4):361-6. PubMed ID: 9690726 [TBL] [Abstract][Full Text] [Related]
4. Beclomethasone dipropionate (3 mg) versus 5-aminosalicylic acid (2 g) versus the combination of both (3 mg/2 g) as retention enemas in active ulcerative proctitis. Mulder CJ; Fockens P; Meijer JW; van der Heide H; Wiltink EH; Tytgat GN Eur J Gastroenterol Hepatol; 1996 Jun; 8(6):549-53. PubMed ID: 8823568 [TBL] [Abstract][Full Text] [Related]
5. Beclomethasone dipropionate enemas for treating inflammatory bowel disease without producing Cushing's syndrome or hypothalamic pituitary adrenal suppression. Kumana CR; Seaton T; Meghji M; Castelli M; Benson R; Sivakumaran T Lancet; 1982 Mar; 1(8272):579-83. PubMed ID: 6121181 [TBL] [Abstract][Full Text] [Related]
6. Treatment of distal ulcerative colitis with beclomethasone enemas: high therapeutic efficacy without endocrine side effects. A prospective, randomized, double-blind trial. Bansky G; Bühler H; Stamm B; Häcki WH; Buchmann P; Müller J Dis Colon Rectum; 1987 Apr; 30(4):288-92. PubMed ID: 3030678 [TBL] [Abstract][Full Text] [Related]
7. Comparison of 5-aminosalicylic acid (3 g) and prednisolone phosphate sodium enemas (30 mg) in the treatment of distal ulcerative colitis. A prospective, randomized, double-blind trial. Mulder CJ; Tytgat GN; Wiltink EH; Houthoff HJ Scand J Gastroenterol; 1988 Oct; 23(8):1005-8. PubMed ID: 3059450 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic benefits from a poorly absorbed prednisolone enema in distal colitis. McIntyre PB; Macrae FA; Berghouse L; English J; Lennard-Jones JE Gut; 1985 Aug; 26(8):822-4. PubMed ID: 3894171 [TBL] [Abstract][Full Text] [Related]
9. A controlled trial of beclomethasone versus betamethasone enemas in distal ulcerative colitis. Halpern Z; Sold O; Baratz M; Konikoff F; Halak A; Gilat T J Clin Gastroenterol; 1991 Feb; 13(1):38-41. PubMed ID: 2007742 [TBL] [Abstract][Full Text] [Related]